Marinus Pharma (MRNS) Misses Q1 EPS by 3c

Marinus Pharma (NASDAQ: MRNS) reported Q1 EPS of ($0.68), $0.03 worse than the analyst estimate of ($0.65). Revenue for the quarter came in at $7.68 million versus the consensus estimate of $9.04 million.

For earnings history and earnings-related data on Marinus Pharma (MRNS) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Bernstein SocGen on Meta Platforms Inc. (META): 'Risk-reward remains attractive'
• Beike (BEKE) PT Raised to $23 at Morgan Stanley